Samsung Biologics Reports Second Quarter 2023 Financial Results

Recorded Q2’23 consolidated revenue of KRW 866.2 billion Recorded Q2’23 consolidated operating profit of KRW 253.4 billion Achieved record-high semi-annual revenue exceeding KRW 1,587.1 billion Strong growth sustained with successful contract wins and full completion of Plant 4 set to…